File:Bupropion bioequivalency comparison.svg

Page contents not supported in other languages.
This is a file from the Wikimedia Commons
From Wikipedia, the free encyclopedia

Original file ‎(SVG file, nominally 1,000 × 650 pixels, file size: 260 KB)

Summary

Description A bioequivalency profile comparison of extended-release bupropion as produced by Impax Laboratories for Teva and Biovail for GlaxoSmithKline.
Note: The generic drug illustrated in this graphic was not affected by the FDA's 300 mg recall and is still available in the United States as of April 2013.[1][2]
Date
Source Own work based on FDA data [3]
Author CMBJ

Licensing

I, the copyright holder of this work, hereby publish it under the following license:
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 3.0 Unported license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

See also

Notes

  1. ↑ (2012-10-03). "FDA Update: Budeprion XL 300 mg Not Therapeutically Equivalent to Wellbutrin XL 300 mg". Food and Drug Administration. Retrieved on 2013-04-29.
  2. ↑ Moeller, Karen E.. "Wellbutrin/Budeprion XL 300 mg". NAMI. Retrieved on 2013-04-28.
  3. ↑
    Time
    (hours)         		Mean plasma concentration, Impax
    (ng/mL)         		Mean plasma concentration, Biovail
    (ng/mL)
    0 0 0
    0.5 5 1
    1 31.5 6.5
    1.5 51 15
    2 62 19.5
    3 60 28
    4 53 46
    5 48 67
    6 38 51.5
    7 33 46
    8 29 39
    10 24 28.5
    12 20 23.5
    16 12 13.5
    24 6.5 8
    Data derived from FDA graphic chart.

Captions

Add a one-line explanation of what this file represents

Items portrayed in this file

depicts

inception

28 April 2013

MIME type

image/svg+xml

checksum

ec11e6dd6b0e5ca8e49e8fd1d1d4bdeaf0da0712

determination method: SHA-1

data size

266,229 byte

height

650 pixel

width

1,000 pixel

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current08:59, 29 April 2013Thumbnail for version as of 08:59, 29 April 20131,000 × 650 (260 KB)CMBJ
02:18, 29 April 2013Thumbnail for version as of 02:18, 29 April 20131,000 × 650 (180 KB)CMBJ
08:33, 28 April 2013Thumbnail for version as of 08:33, 28 April 2013700 × 500 (32 KB)CMBJ
05:58, 28 April 2013Thumbnail for version as of 05:58, 28 April 20131,000 × 500 (41 KB)CMBJ
04:35, 28 April 2013Thumbnail for version as of 04:35, 28 April 20132,100 × 1,000 (39 KB)CMBJ{{Information |Description=Note: The generic drug illustrated in this graphic was not affected by the FDA's recall and is still available in the United States as of April 2013.<ref name='Moeller'> {{cite news | first = Karen E. | last = Moeller | title...
The following pages on the English Wikipedia use this file (pages on other projects are not listed):

Global file usage

The following other wikis use this file:

Metadata

This file contains additional information, probably added from the digital camera or scanner used to create or digitize it.

If the file has been modified from its original state, some details may not fully reflect the modified file.

Retrieved from "https://en.wikipedia.org/wiki/File:Bupropion_bioequivalency_comparison.svg"